Esperion Therapeutics (ESPR) Net Cash Flow Growth (5y) (2017 - 2026)
Esperion Therapeutics (ESPR) Net Cash Flow Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.06% |
| Dec 31, 2025 | -3.31% |
| Sep 30, 2025 | 15.74% |
| Jun 30, 2025 | -17.00% |
| Mar 31, 2025 | -12.47% |
| Dec 31, 2024 | 14.88% |
| Sep 30, 2024 | 6.49% |
| Jun 30, 2024 | -18.90% |
| Mar 31, 2024 | 0.75% |
| Dec 31, 2023 | -39.00% |
| Sep 30, 2023 | -64.24% |
| Jun 30, 2023 | 0.01% |
| Mar 31, 2023 | 49.72% |
| Dec 31, 2022 | -52.67% |
| Sep 30, 2022 | 123.69% |
| Jun 30, 2022 | -123.84% |
| Mar 31, 2022 | -26.18% |
| Dec 31, 2021 | 68.85% |
| Sep 30, 2021 | -109.38% |
| Jun 30, 2021 | -35.94% |